Evidence map›Paper›PMID 40662636›Full record

ArticleStatistics in medicine2025

Robust Transfer Learning for High-Dimensional GLM Using

Fuzhi Xu, Shuangge Ma, Qingzhao Zhang, Yaqing Xu

Abstract read
In one paragraph

Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fuzhi XuInternational Institute of Finance, School of Management, University of Science and Technology of China, Anhui, China.
Shuangge MaDepartment of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0001-9001-4999
Qingzhao ZhangThe Wang Yanan Institute for Studies in Economics, Xiamen University, Fujian, China.
Yaqing XuSchool of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0001-7056-4301

Funding

Yale SPORE in Skin CancerP50CA121974 · NCI · YALE UNIVERSITY · PI RUTH HALABAN · 2006 to 2026
$43.9M
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung CancerP50CA196530 · NCI · YALE UNIVERSITY · PI Kurt A Schalper · 2015 to 2026
$31.1M
Novel methods for identifying genetic interactions in cancer prognosisR01CA204120 · NCI · YALE UNIVERSITY · PI Shuangge Ma · 2016 to 2026
$3.5M
Humanities and Social Science Fund of Ministry of Education of China 24YJA910007National Natural Science Foundation of China 71988101National Natural Science Foundation of China 82204153NCI NIH HHS P50 CA121974NCI NIH HHS P50 CA196530NCI NIH HHS R01 CA204120NIH HHS CA121974NIH HHS CA196530NIH HHS CA204120
6 · The paper itself

Abstract

In the analysis of complex diseases, high-dimensional profiling data is important for assessing risks and detecting biomarkers. With the increasing accessibility of cancer genomic data, the sample sizes remain limited in most studies. Hence, borrowing information from additional data sources is thus desirable to improve estimation and prediction. Transfer learning has been demonstrated to be flexible and effective in boosting modeling performance with a record in biomedical applications. In practice, outliers and even data contamination often occur. However, existing transfer learning methods often lack robustness to outliers and data contamination, issues commonly observed in real-world biomedical data. In this study, we propose a robust transfer learning approach based on the minimum

Indexed as

GenomicsMachine LearningNeoplasmsAlgorithmsBreast NeoplasmsComputer SimulationHumansLinear Modelshigh‐dimensional datarobustnesstransfer learning

Identifiers

PMID40662636
PMCPMC12313224

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.